NASDAQ: IONSIonis Pharmaceuticals Inc Stock Ownership - Who owns Ionis Pharmaceuticals?
Insider buying vs selling
Have Ionis Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Patrick R. Oneil | CLO;EVP | 2026-08-31 | 63 | $51.31 | $3.23kBuy |
| Brett P. Monia | CEO | 2026-08-31 | 98 | $51.31 | $5.03kBuy |
| C. Frank Bennett | CSci;EVP | 2026-08-31 | 110 | $51.31 | $5.64kBuy |
| Brian Birchler | EVP | 2026-08-31 | 58 | $51.31 | $2.98kBuy |
| Michael R. Hayden | Director | 2026-07-31 | 5,000 | $51.60 | $258.00kBuy |
| Michael R. Hayden | Director | 2026-07-30 | 15,000 | $53.38 | $800.70kBuy |
| C. Frank Bennett | EVP Chief Scientific Officer | 2026-07-07 | 5,536 | $83.58 | $462.69kSell |
| Allene M. Diaz | Director | 2026-07-07 | 10,111 | $47.11 | $476.33kBuy |
| Allene M. Diaz | Director | 2026-07-07 | 10,111 | $85.42 | $863.64kSell |
| Holly B. Kordasiewicz | EVP Chief Development Officer | 2026-07-07 | 362 | $84.30 | $30.52kSell |
IONS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when IONS insiders and whales buy or sell their stock.
IONS Shareholders
What type of owners hold Ionis Pharmaceuticals Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Lilly Co Eli | 1.50% | 2,500,000 | $111.25M | Insider |
| Stanley T. Crooke | 0.80% | 1,324,914 | $58.96M | Insider |
| Joseph H. Wender | 0.17% | 277,170 | $12.33M | Insider |
| Brett P. Monia | 0.15% | 242,760 | $10.80M | Insider |
| Spencer R. Berthelsen | 0.10% | 161,443 | $7.18M | Insider |
| Brian Birchler | 0.06% | 102,883 | $4.58M | Insider |
| Elizabeth L. Hougen | 0.05% | 82,660 | $3.68M | Insider |
| Michael R. Hayden | 0.05% | 82,298 | $3.66M | Insider |
| Eugene Schneider | 0.05% | 77,114 | $3.43M | Insider |
| Frederick T. Muto | 0.04% | 74,597 | $3.32M | Insider |
IONS vs Biotech Stocks
Ionis Pharmaceuticals Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.